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1 
INTRODUCTION 
 
The most common pituitary tumour is adenoma, that accounts for 10 -15% of all 
intracranial tumour that originate from epithelial cells of pituitary. Depending  on size of 
the adenoma it is classified as  microadenomas[<10mm] and macro adenomas[>10mm] 
Pituitary macroadenomas are enclosed/ invasive or expanding [snow man or dumbell 
shaped]. The various modes of presentation are A) non secretory/non functional type       
that can   be asymptomatic or produce mass effects like headache,visual defects,vomiting 
etc B)secretory/functional type-producing hormonal imbalance. 
The role of imaging techniques has implication in surgery based on the tumour size, 
extent and consistency  that determines the ease of resection ,  cure and occurence of 
complication. 
The transnasal  trans-sphenoidal endoscopic approach  recently been applied procedure 
minimally invasive to ressect pituitary  tumours . 
By reviewing various surgical techniques for radical/complete exicision of tumour with 
restoration of vision and preservation of pituitary functions that are fullfilled with 
minimum morbidity and mortality. 
The study also deals with per operative and post operative complications and their 
management 
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AIMS AND OBJECTIVES OF THE STUDY 
 
Aim : To Study about the  Pituitary Macroadenoma- Transnasal Endoscopic Excision 
Objectives : 
1.To study the modes of presentation of pituitary macroadenoma 
2.To evaluate radiological study of the tumour by computed tomography (CT)  /magnetic 
resonance imaging ( MRI) and its implications in   surgical techniques 
3.To review the surgical techniques in complete excision of  the macroadenoma 
4.To study the per operative and post operative complications and  its management   
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ANATOMY 
DEVELOPMENT OF PITUITARY GLAND 
      From the developing embryo the pituitary originates with two parts 1) dorsal 
evagination of stomodeum known as Rathke‟s pouch that is anteriorly immediate to  
buccopharangeal membrane with a ventral extension  caudally to optic chiasma of 
diencephalon known as  infundibulum , both are derivatives of ectoderm.2)The pouch of 
Sessel is another dorsal evagination of stomodeum arising posteriorly from 
buccopharyngeal membrane.
1,2 
MORPHOGENESIS 
     The glandular epithelium is differentiated from Rathke‟s pouch and is characteristic of 
other endocrine organs.The exocrine ductless tissue is formed by infundibulum.The 
anterior end of notochord situated caudal to stomodeum induces glandular and neural 
primordial leading to development of hypophysis. 
         At 3
rd
 week of intrauterine life
3
 , ventral diverticulum in the floor of third ventricle 
developed from infundibulum  leading to infundibular process by extension from median 
eminence known as infundibular stem.Dorsally an ectodermal placode appear in 
stomodeum roof and form Rathke‟s  pouch by invagination simultaneously. 
          By 2
nd
 month of intrauterine life , intergration of Rathke‟s pouch and infundibulum 
occurs by flattening of former with anterior and laterl surface of latter. There occurs pass 
through of chondrification centers of developing presphenoid and basisphenoid skull 
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bones due to connection between Rathke‟s pouch and oral cavity.By 6th  week ,expansion 
of sphenoidal mesenchyme leads to regression of this connection. 
   Remnants of Rathke‟s pouch during its course if persists in oropharyngeal roof or in 
sphenoid bone presents as pharyngeal hypophysis or as basipharyngeal canal. The 
anterior lobe of pituitary (adenohypophysis) is formed by the cellular proliferation of 
Rathke‟s pouch‟s anterior wall-pars distalis. The pars intermedia is of less active  walls of 
posterior  Rathke‟s pouch4{cells do not proliferate extensively but differentiated},upward 
growth of anterior wall forms pars tuberalis. The Rathke‟s pouch which is incompletely 
obliterated ieads to remenant to form rathke‟s cleft/pituitary fissure. The  differentiation 
of neural ectoderm into pars nervosa, infundibular stem and median eminence leads to 
development of neuro hypophysis 
Infundibular stem is surrounded by pars tuberalis together comprises pituitary stalk.The 
neurohypophysis consists of neuroglial cells(pitucytes)as well as nerve fibres and 
terminal cells originating from hypothalamic nuclei.Apart from secretion and transport of 
hormones from neurohypophysis, pituicytes  have phagocytic activity. 
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DEVELOPMENT OF PITUITARY 
 
 
FIG-1 
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A:Infundibulum and Rathke's pouch develop from neural ectoderm and oral ectoderm, 
respectively. B: Rathke's pouch constricts at base. C: Rathke's pouch completely 
separates from oral epithelium. D: Adenohypophysis is formed by development of pars 
distalis, pars tuberalis, and pars intermedia; neurohypophysis is formed by development 
of pars nervosa, infundibular stem, and median eminence. 
 
HISTOGENISIS 
                 The third and fourth month of gestation anterior lobe cells arranged cords 
around blood sinuses with surrounding mesenchyme inducing glandular organisation.By 
first
5
  trimester the portal blood vessels are fully established.differenciation of anterior 
lobe cells characterised affinity of cytoplasm  into acidophilic basophilic and 
chromophobes.Basophilic cells concentrated in pars medialis whereas acidophilic cells 
are concentrated inpars lateralis.the early detected hormones are corticotrophs 
betaendorphin and leutinising hormone and follicular stimulating hormone.Trh developed 
in early second trimester .during second half of pregnancy growth hormone and -
prolactin are synthesised.In late fetal life neurosecretory activity of posterior lobe begins. 
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ANATOMY OF PITUITARY AND SELLAR REGION 
 
FIG-2 
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      Sellar anatomy- the sphenoid bone is the entry for skull base that is located in the 
centre of skull base.recently the endoscopic endonasal approach to skullbase iss accesss 
to the middle of the skull base.the bony constituents of sella turcica forms the limitation 
of the pituitary fossa anteriorly posteriorly and inferiorly .the average bone thickness is 
0.4mm .the average distance from fossa is 14 to 17 cm.anterior boundary of pituitary 
fossa forms tuberculum sella whereas posterior boundary forms dorsum sella. A minimal 
groove lie at optic foramen which forms chiasmatic sulcus . The sellar tuberculum lies 
posterior and sphenoidale planum  anterior to the chiasmatic sulcus. 
          Rounded knob like structures formed by supralateral margins of dorsum sella 
called as posterior clenoid process.The middle clenoid process are lateral to the 
tuberculum sella .Anterior clenoid process located in the medial wing of  lesser wing 
sphenoid. 
       The dorsum sella is continuous as clivus the superior portion of which is formed by 
bone of sphenoid and inferior portion is formed by bone of occiput.Along  lateral surface 
of the body of sphenoid extends the carotid sulcus.Hypophyseal floor is formed by roof 
of sphenoid sinus partly/completely. 
     Sphenoid sinus is subject to considerable variation in size shape and to degree of 
pneumatisation. Adult sphenoidal sinuses based with pneumatisation are –conchale 
,presellar and sellar type.Conchale type - a solid block of bone with out                                                                                            
aircavity area below sella.Presella type -penetrtion aircavity doesnot occur beyond 
vertical plane parallel to anterior sellar wall. Sellar type-aircavity enters extends into 
body of sphenoid below the sella as posteriorly as the clivus.The septa/bony trabeculae 
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within sphenoid sinus vary in size , shape , thickness and location and completeness and 
relation to the sellar flow.Only in 20% of cases inter sinus septum is attatched to 
midpoint of anterior sella and may be absent altogether.The posterior attatchment of inter 
sinus septum to serpeginous prominence produced by carotid artery into the sinus wall 
below the floor and along the anterior margin of the sella.Usually optic canal protrude 
into supra lateral portion of the sella and infrolateral part of the second division of 
trigerminal nerve protrudes. 
    High variability of Sella contour –round/ oval /profile with flattened although .At birth 
shallow depression at sella dorsum ossification not occurred. By approximately four 
years of age  sella outline appears more rounded .Diaphragma sella forms the incomplete 
roof of sella turcica covering the pituitary gland except a central opening for transmitting 
pituitary stalk.The shape of diaphragm sella is more of rectangular and has  convexity or 
concavity. 
   The anterior lobe of pituitary from overlying optic chiasma is separated by diaphragm 
sella.The margins of diaphragm are attatched to the tuberculum sella , anterior clinoid 
process and dorsum sella superior aspect.The lateral wall of  pituitsry fossa is by lateral 
continuation of diaphragm with dural folds.The variable size in central aperture of 
diaphragm ranging from a small foramen to a large hole surrounded by a tenacious 
membrane of tissues.A deficiency in diaphragm sella is preconditioned to form empty 
sella.Though this central opening in diaphragm sella an outpouching arachnoid protrudes 
in 50% of cases indicates important source of post operative cerebrospinal leak.. 
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   PITUITARY GLAND-it is a pea shaped gland situated in fibro osseous compartment 
within the hypophyseal fossa at the centre of the skull base.It  weighs  about 100 mg  
averagely at birth.The size in adults is 10 mm in length ,10-15 mm width and 5 mm 
height.Female gland is 20% heavier  than the male gland. The weight of the gland 
increases by 12 to 100 %  during pregnancy.Accurate size can be measured with 
MRI.Volume of pituitary gland decreases with aging. The lower part of the pituitary stalk 
is wrapped by anterior lobe to form pars tuberalis.Compared to anterior lobe posterior 
lobe is more adherent to sella wall. 
   In most patients the width of the gland is equal or more in its length / height.The Shape 
of sella floor is confirmed by inferior surface of the gland .Even the lateral and superior 
margin ary in shape as the walls are composed of soft tissue rather than bone.The gland 
tends to be concave superiorly in the area around the stalk  if there is a large opening in 
the diaphragm.As a result of compression of gland laterally and posteriorly by carotid 
artery the superior surface is triangular.The tendency of pars tuberalis to be retained with 
posterior lobe as anterior lobe is  separated from the posterior lobe.During separation of 
anterior and posterior lobe the intermediate lobe cysts are frequently encountered. 
   PARASELLAR/SUPRASELLAR ANATOMY-the lateral wall of hypophyseal fossa 
formed by folds of duramater contains cavernous sinuses consisting serially arranged 
compartments of venous channels  separated by fibrous trabeculae. 
   The communication between two cavernous sinuses leads to intercavernous connection 
named on the basis of relationship to pituitary gland i.e. anterior intercavernous  sinus 
runs anterior to diaphragma  sella and posterior intercavernous sinus behind the pituitary 
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stalk.The anterior sinus is usually larger than the posterior sinus but either or both maybe 
absent if connections coexists forms circular sinuses.The lateral wall of cavernous sinus 
the occulomotor nerve ,trochlear nerve and first two divisions of   trigerminal nerve are 
embided lying between the dura and the endothelial lining but 6
th
 cranial nerve is present 
with the sinus.  A small portion of the internal carotid artery encircled with sympathetic 
nerve trunk is enveloped by cavernous sinus.The forward extension cavernous segment of 
internal carotid artery( ICA) is adjascent to supralateral surface of body of sphenoid 
bonewith groove known as carotid sulcus.The ICA courses superiorly medial to the 
anterior clinoid process at the anterior end of carotid sulcus and pierces the dura and 
enters subarachnoid space.ICA medial limitus approximately 5 mm awayfrom midline 
whereas lateral limit vary from 13-20 mm from midlineThe Suprasella region- over the  
hypophysis is hypothalamus and visual pathways. 
   Depending upon the variations in the development of sphenoid bone just anterior 
hypophyseal fossa producing inconsistency in the relation between pituitary gland, stalk 
,diaphragma sella and sulcus chiasmaticus.The variations are 
 1.body of sphenoid bone develops so that sulcus chiasmaticus is more inferior than usual 
known as  prefixed chiasma present in 10% of cases. 
2.intracranial course of optic nerve is slightly larger than the preceding pattern .Therefore 
the entire optic chiasma rests above the anterior part of diaphragma sella leading to most 
vulnerable of optic chiasma to supra sellar extension of pituitary tumour in 12% of cases. 
3.optic chiasma most posteriorly placed than previous arrangement in 75% of cases. 
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4.optic chiasma located on and behind dorsal sella leads to vulnerability of the medial 
aspect of optic nerve when suprasellar extension of intrasellar tumour. 
   Nerve supply -The anterior pituitary has no direct nerve supply other than autonomic 
nerves. The posterior lobe, in contrast, is composed almost exclusively of hypothalamic 
nerve fibres.Hypothalamic projections release hormones and trophic factors by 
neurosecretion into the median eminence and portal system. There are two principal 
tracts; the hypothalamo-hypophyseal tract arises in the magnocellular neurones of the 
supraoptic and paraventricular nuclei and releases vasopressin and oxytocin into the 
posterior pituitary, the parvocellular neurones of the tubero-infundibular tract originate in 
multiple hypothalamic nuclei and project to the median eminence. 
    Circulatory supply The adenohypophysis and hypothalamus share a complex portal 
blood supply carrying trophic and inhibitory hormones from the hypothalamus, thus 
regulating systemic release of anterior pituitary hormones. The anterior pituitary has no 
direct arterial supply.Branches of the superior, middle and inferior hypophyseal arteries 
supply the median eminence and posterior pituitary. The superior hypophyseal arteries 
branch into an internal and external plexus. The internal plexus forms glomeruloid 
structures known as gomitoli. Gomitoli regulate the flow of regulatory hormones in the 
pituitary paracrine „biological network‟ and are the presumed origin of sellar 
glomangiomas. The inferior arteries supply the pituitary capsule, the neural lobe and the 
pituitary stalk.The venous drainage of the pituitary gland is to the inferior petrosal sinuses 
via the cavernous sinus.The capacity of the venous drainage is exceeded by the volume of 
blood entering the gland, thus forming a reservoir. Reversal of blood flow here results in 
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secretory products from the adenohypophysis entering the neurohypophysis and median 
eminence. This vascular anatomy is  important in the pathophysiology of apoplexy. 
 
 
 
FIG-3 
 
SELLAR AND   PARASELLAR REGION 
(ENDOSCOPIC AND ENDONASAL ANATOMY)  
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PHYSIOLOGY OF PITUITARY 
            Pituitary gland consists of two principle lobes anterior lobe, posterior lobe and 
intermediate lobe situated between anterior and posterior lobe .Anterior lobe secretes 
following hormones growth hormone (GH) ,thyroid stimulating hormone(TSH), 
adenocortico trophic hormone (ACTH) ,gonadotrophic hormone (GnRH)-a)follicular 
stimulating hormone b)leutinizing hormone prolactin 
       Secretion of anterior pituitary hormone is governed  by hormones from median 
eminence of hypothalamus .Cortico tropin, prolactin and growth hormone are simple 
polypeptides whereas leutinizing hormone follicle stimulating hormone ,and thyroid 
stimulating hormones are glycoproteins . 
      The glycoproteins are made up of two subunits (heterodimer namely alpha and 
beta).Alpha subunits hormones  reproducts of chromosome 6 of a single gene.Beta  
subunits  varying in structure produced by different genes.Secretions of  alpha subunits 
only describe with the context of non functioning  pituitary adenoma. 
       Serum levels of anterior pituitary hormones along with alpha subunit can be 
measured by radio immunoassay.Growth hormone-the somatotroph of anterior pituitary 
secretes peptide hormone known as growth hormone. Growth hormone releasing 
hormone(GHRH) 
Stimulates secretion of growth hormone. Somatomedin-exerts range of wide metabolic 
actions.Hypoglycemia increase plasma levels of aminoacids ,decrease plasma free fatty 
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acids ,inhibits uptake of glucose by most of tissues.Glucose is conserved for brain use by 
anti insulin action,promotes lipolysis-non carbohydrate substrate for ATP generation. 
        Synthesis of protein is promoted by GH and is crucially needed between the age of 
three years and puberty for normal skeletal growth.
 
Synthesis of IGF and its secretion 
stimulated by growth hormone.The cartilage cells derived and deposited at epiphyses 
(growth plate ) is encouraged and enhanced by IGF. 
       The pituitary gland normally secretes GH with a molecular weight of 
22000.Corticotrophic hormones-seccreted by anterior pituitary corticotrophs.The action 
of corticotrophin for the basal secretion of glucocorticoids and aldosterone as well as 
hormones produced by various stresses act on the adrenal gland.Rapid atrophy of adrenal 
cortex occurs after hypophysectomy. It is a polypeptide containing 39 aminoacids with its 
half life in circulation approximately 10 minutes.participating in rapidly adjustment of 
circulatory levels of glucocorticoids is due to this half life property . 
       ACTH regulates the secretion of glucocorticoids steroid hormones and responds to 
stress.Pituitary glycoprotein hormones-TSH ,FSH ,LH .TSH regulates the secretions of 
thyroxine (t4) and tri-iodo thyronine.These secretions are regulated by hypothalamic 
TRH.A triangular peptide in medial part of paraventricular nucleus . 
      TSH contains 211 aminoacids and biological half life is 60 minutes.TSH secretion is 
pulsatile and peaks out during midnight.TSH acts on cell receptors and activates adenalyl 
cyclise through a GTP binding protein.TRH is increased during exposure to cold 
temperature.By feedback inhibition T3 AND T4 levels are blocked by TSH. 
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          FSH and LH –Regulates the function of gonads.The secretion is influenced by 
hypothalamic gonadotrophic releasing hormone(GnRH) which is a decapeptide. In 
females FSH helps preparation for ovulation and secretion of estrogen by growing 
follicle. LH triggers ovulation and production of progesterone by corpus leuteum.I FSH is 
needed for spermatogenesis while LH  produces testosterone  by leydig cells in 
males.The half life of FSH is 170 minutes that of LH is 60 minutes. 
          Secretion of GnRH is pulsatile for purpose of reproduction and endocrine 
function.Inhibin synthesised in gonads of both sexes is a polypeptide inhibits FSH . 
           PROLACTIN(PRL)-contains 198 aminoacid residues .Half life is 20 minutes 
similar to growth hormoneand the receptors also resemble growth hormone and 
undergoes dimerisation before activating several intra cellular enzyme cascades .PRL 
secretion is usually inhibited by hypothalamic prolactin inhibiting homone or prolactin 
inhibiting factor called dopamine.Hormonal release is generated in response to sucking 
inhibits the hypothalamic dopamine release in lactating women .Prolactin inhibits the 
action of gonatrophin on ovary that prevents ovulation during lactation or those with 
prolactin secreting tumour.Excessive prolactin in male leads to impotence. 
            Physiology of intermediate lobe-about 3.5% of glandular mass of pituitary is cells 
of pars media in  human fetus but less than 1% in adults. The pars intermedia synthesise 
POMC, a large protein  precursor .The principal products of POMC hydrolysed to form 
CLIP,gamma lipoprotein, beta endorphin and melanotrophins.  
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            The intermediate lobe form two melanotrophins , alpha –MSH and beta MSH 
where beta MSH controls migration of pigment molecules.melanin synthesis is due to 
MSH molecule binded to melanotrophin 1 receptor on melanocytes. 
            Physiology of posterior pituitary-Oxytocin and Vasopressin are the hormones of 
posterior lobe.The latter also called as  anti diuretic hormone(ADH),as one of its 
principal physiological effects is retention of water by kidneys.In response to electrical 
activity at the axon endings posterior lobe hormones are released in to general 
circulation.Both these hormones contains nonapeptides with a disulfide ring at one 
end.Synthesis of these hormones occurs in the cell bodies of the magnocellular neurons 
of supraoptic and paraventricular nuclei of hypothalamus.Supraoptic fibres mostly end in 
posterior lobe itself whereas paraventricular fibres some end in median eminence as well. 
Release of stored hormones is trigerred  by calcium-dependent exocytosis in response to 
action potential. 
           Oxytocin-Action of oxytocin  occurs through G-protien-coupled receptors of cell 
surface, triggering of which increases intracellular calcium in response to 
activation.Oxytocin casues contraction of myoepitheleal cells lining the breast 
ducts.Tactile stimulation of nipples leads to flow of milk from alveoli of 
breast.Contraction of utrine smooth muscles during delivery leads to fetal descent and 
enhances labour and in non pregnant uterus acts by facilitation of sperm passage in to 
fallopian canal.In men  oxytocin increases at the time of ejaculation that propels sperm 
towards urethra by contraction of vasdefrens smooth muscle. 
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           Vasopressin (ADH-Antidiuretic hormone)-Vasopressin action through cell surface 
receptors namely,serpentine,transmembrane and G-protien coupled receptors leads to 
formation of second messanger and exerts many physiological effects on 
body.Vasopressin‟s half life biologically is 18 minutes.  
           Action on collecting ducts: permea bility of collecting duct is increased by 
aquaporin  water channels translocation from endosomal compartment to luminal side 
enables entry of water to the hypertonic interstium of renal pyramid.This leads to 
decrease in urine volume and increase in concentration of urine. Conditions that increases 
ADH are decreased blood volume,increased plasma osmotic pressure, increased 
angiotensin II levels,pain ,emotion and exercise.ADH secretion is inhibited  by 
alcohol.Vasopressin is potent vascular smooth muscle constrictor and also acts by 
paracrine action on anterior pituitary and releases corticotrophin  hormones. 
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FIG-4 
 
PHYSIOLOGY OF PITUITARY 
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REIVIEW OF LITERATURE 
HISTORCAL RIVIEW 
                      Scholffer in1906 was first person to succesfully remove the pituitary 
tumour via trans sphenoidal approach and considered to be safe.In 1909,Hirsch used 
submucosal resection of septum and endonasal approach.1910-A.E.  
                    Halstead‟s description of sublabial gingival incision for initial stage of 
exposure.By 1914,Harvey Cushing combined sublabial incision with submucosal septal 
approach,preserving nasal functions without an external scar with contemporary to 
OskarHirsch,operated 231pituitary tumours with mortality of 5.6%. 
                   Cushing got expertise in transcranial surgery and able to verify supra sellar 
tumour and achived decompression of optic apparatus better, resulting in better  recovery 
of vision and lower reccurrence rate however,the mortality rate is reduced to4.5%.As 
Cushing influenced neurosurgery world wide,his shift from the trans sphenoidal to 
transcranial approach was to influence the destiny of pituitary surgery for many years to 
come.  
                 At a period of time the trans nasal surgery was abandoned by Cushing himself 
and all other neurosurgeons  went in favour of transcranial approach.Norman Dott , a 
visiting scholar passed through Edinborough ,Scotland because of his work the lineage 
that kept the transphenoidal procedure alive where others persued  transcranial 
approach.Dott appreciated the merits of transsphenoidal procedure during his stay in 
Boston fromNovember 1923 to June 1924.He designed instruments specifically for the 
transphenoidal procedure. In 1956 Gerad Guiot ,a pupil of the legendary French Neuro 
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surgeon Clovis Vincent visited Normann Dott and had a chance of observing 
transphenoidal operation. 
                Guiot introduced intra operative  radiographic control and intra operative 
fluoroscopy during transphenoidal surgery.Guit in 1958 presents its first few papers of 
pituitary adenoma operated on transphenoidally in front of French society of neuro 
surgery and revived the interests of many physicians throughout Europe. 
               Joules Hardy decided to try the transhenoidal route and able to perform 
hypophysectomies in a dark ,deep and narrow field.He also introduced operating 
microscope for the refining the procedure. 
                    The concept of microadenoma was introduced by him and demonstrated 
surgical cue to be  possible in case of small hypofunctioning adenomas and significantly 
increases the efficacy and surgical morbidity.In 1970 the development of endoscopy 
occurred ,in 1992 Jankowski et al performed endoscopic transnasal transhenoidal 
approach,then in 1996 Jho et al described entirely endoscopic transnasal transphenoidal 
approach. 
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FIG -5:Harvey Williams Cushings         FIG-6 : Normann Dott 
 
 
 
                                     
  
        FIG-7:   Gerad Guiot                                             FIG -8: Hardy Jules 
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“Pituitary macroadenoma-The sellar region is a site of various types of tumors. Pituitary 
adenomas are the most common. They arise from epithelial pituitary cells and account for 
10-15% of all intracranial tumors. Tumors exceeding 10 mm are defined as 
macroadenomas, and those smaller than 10 mm are termed microadenomas. Most 
pituitary adenomas are microadenomas”. 
Pathophysiology “The cause of pituitary macroadenomas is unknown. The most 
acceptable theory attributes monoclonal neoplastic transformation of pituitary cells 
leading to tumor initiation and growth. The monoclonal nature of most pituitary tumors 
and their retention of a response to negative feedback by hormones produced by target 
organs support this hypothesis.”                                                                                                                                                   
Pituitary macroadenomas are epithelial tumours , benign in nature and consists of   
anterior pituitary cells. Primary pituitary tumors that are malignant are not common. The 
development of pituitary adenoma has irreversible initiation phase followed by tumor 
promotion phase . Heredity ,hormonal and genetic mutations influence development of 
pituitary macroadenoma . The monoclonal nature of most pituitary tumors indicates that 
they arise from    a mutated pituitary cell.  
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A report suggested that patients with pituitary tumors from 4 Irish families share a 
common mutation with a patient from the 18th century who had pituitary tumor–
mediated gigantism indicating the role of genetic mutation.  
“Specific immunochemical stains permit differentiation of anterior pituitary cells into 
somatotrophs (growth hormone; GH), lactotrophs (prolactin), thyrotrophs (thyrotrophin; 
TSH), gonadotrophs (luteinising hormone and follicle-stimulating hormone; LH and 
FSH) and adrenocorticotrophs (adrenocorticotrophin; ACTH).” Any of these cell  types 
can give rise to functional or silent adenomas. Mutations in the Ikaros gene and cell cycle 
proteins are implicated in pituitary tumorigenesis. Pituitary adenomas can be 
differentiated from normal pituitary tissue by the loss of the nodular reticulin framework 
and uniform immunohistochemical staining with a single pituitary hormone.  
Adenomas may be hormonally inactive, presenting particularly with visual field defects, 
headaches, nausea and vomiting. Tumours that secrete hormones often produce clinical 
symptoms corresponding to the systemic effects of the hormone concerned. Adenomas 
often maintain some degree of hormonal regulation and pituitary carcinomas are rare, 
supporting the concept of „reversible plasticity‟ in pituitary adenomas. Aggressive nature 
of pituitary adenomas can be predicted by over expression of the cell proliferation marker 
Ki67 (Mib-1) or increased expression of the p53protien. 
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Various modes of presentation 
“Pituitary tumors can be either secretory or non-secretory, stating to whether they 
overproduce pituitary hormones. Secretory tumors cause disease because of the excess 
quantities of hormones which they secrete (release) into the bloodstream. The most 
common type of secretory pituitary tumor is termed as prolactinoma. Excess prolactin in 
the blood may lead to irregular or absent periods in women, decreased libido and 
erections in men and infertility or milk production in men or women. However, there are 
excellent medicines available to treat this disorder, so surgery is rarely needed. Most 
patients with prolactinomas are treated by endocrinologists, who are medical specialists 
in gland and hormone disorders”.  
“Secretory tumors, that commonly require surgery, include those which cause 
acromegaly and Cushing's disease. Acromegaly (or gigantism if occurring in a child) 
results from an too much of growth hormone production‟‟. Excess of adrenocorticotropic 
hormone (ACTH) leads to overproduction of cortisol by the adrenal glands, giving rise to 
a disorder called Cushing's disease. Surgical removal of these tumors can restore normal 
hormone production in many cases. “Non-secretory tumors ( "non-functioning") do not 
overproduce hormones, but cause problems due to their size and location. This is because 
they can compress both the normal pituitary gland and the surrounding structures. 
Hormone deficiencies may result from compression of the normal pituitary gland. Non-
secreting tumors can also cause vision defects by growing upwards and compressing the 
optic nerves and chiasma, nerves which are essential for vision. This pressure can lead to 
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loss of peripheral vision. Surgical  removal such tumors  relieves the pressure on 
structures surrounded by” 
Symptoms: 
“Tumors in asymptomatic patients may be discovered when imaging the head for 
unrelated medical conditions. The frequency of diagnosis of pituitary tumors has 
increased with widespread use of computed tomography (CT) and magnetic resonance 
imaging (MRI) scans.”  
“Pituitary hormone effects depend on the hormones involved. Panhypopituitarism may 
present with a deficiency of all the pituitary hormones, but often some are spared. The 
larger the tumor, the more likely it is to involve most hormones. Anterior pituitary cells 
are not equally sensitive to mass effects. The most sensitive are the somatotrophs and the 
gonadotrophs, whereas corticotrophs and thyrotrophs tend to be more resistant. Distinct 
clinical syndromes, specifically the following, are the result of the hormonal activity of 
the tumor” . Hyperprolactinemia manifests as hypogonadism, infertility, amenorrhea, and 
galactorrhea. due to increased hormone production by a prolactinoma, or due to stalk 
compression by the tumour. Cushing disease occurs due to corticotropin excess 
.Corticotropinomas are rarely macroadenomas. Compression of the normal corticotrophs 
causes  corticotropin suppression and leads to glucocorticoid insufficiency. secondary 
hyperthyroidism arises with thyrotropin excess. Thyrotropinomas are uncommon and  
frequently present as macroadenomas. Biologically inadequate thyrotropin presents with 
secondary hypothyroidism. 
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Excess growth hormone result in  acromegaly due to somatotropinoma. Failure to thrive 
in children  is seen in GH insufficiency but not so in adults.  
Gonadotropinomas most often are asymptomatic and are macroadenomas resulting in 
hypopituitarism. Testicular enlargement in men and ovarian hyperstimulation in women 
are its uncommon features. Hypogonadism and infertility  occur due decrease of 
gonadotropins .  
Visual defects, headache, raised intracranial pressure, or intracranial bleed are due to 
pressure effects of the macroadenoma..  
Pituitary apoplexy results from infarction of a pituitary tumor or sudden hemorrhage 
within. It is a medical emergency. It presents with headache, sudden collapse, shock, and 
death if not treated emergently. This tends to occur in macroadenomas. Administration of  
TSH, GnRH, and insulin-hypoglycemia, increases the metabolic needs by the 
macroadenoma, leading to necrosis. Presenting symptom of a gonadotropinoma in an 
elderly men receiving GnRH agonist therapy for prostate cancer may be apoplexy.  
Nelson syndrome results from treatment of Cushing disease with bilateral adrenalectomy.  
Lack of negative glucocorticoid feedback leads to excessive tumor growth which are 
aggressive in nature.   
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Signs 
Mostly  patients associated with macroadenomas are asymptomatic. Physical findings are 
due to mass effects or hormonal disruption. Visual field defects appear when tumour 
extends on to optic chiasma  . Sudden enlargement in tumor size, due to hemorrhage, may 
lead to raised intracranial pressure. Hyperthyroidism, Cushing syndrome, or 
hyperprolactinemia are manifestation of target organ stimulation in secretory tumours . 
Mirian Cabral et al
6
 reported that most prevalent tumour was the producer of GH(7.6%), 
followed by prolactinoma(6.9%), and adrenocorticotropic hormone(6.2%). Thyrotrophic 
hormone producing tumour was very less (0.7%).  
Omar López Arbolay etal 
7
  reported that among 238 patients with macroadenomas and 
40 with microadenomas were operated on using the EEA technique. 92 were functioning 
tumors and 186 non-functioning. Headache and visual field defects were the most 
common complaints in patients with non-functioning adenomas. In patients with 
secreting tumors modes of presentation depended on the increased hormone. 
Role of imaging techniques and surgical implication 
In adults most common suprasellar mass is pituitary macroadenoma that is responsible 
for trans sphenoidal hypophysectomy in majority of cases. Solid tumours with attenuation 
similar to brain (30-40 hounse field with moderate contrast enhancement) in MRI T1 and 
T2 weighted images show isointense to the grey matter , these attenuation and signal 
characters however vary significantly depending on tumour components such as 
hemorrage , cystic transformation and necrosis.
8 
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In CT scan contrast attenuation cannot vary on hemorrhage,cystic mass and 
necrosis.pituitary adenomas are isodense to adjasceent brain parenchyma on unenhanced 
CT.They demonstrate intense contrast enhancement after injection of contrast 
material.Bony erosion and expansion of sella turcica are well demonstrated on bone 
window images.Calcification is less common in 5% of cases.Hemorrahge within pituitary 
tumour is rare that can be detected as focal hyper density.Solid adenomas without 
hemorrhage typically have attenuation similar to brain and demonstrate isodense on 
enhancement
9
. 
 MRI is the most powerful modality for delineating the mass and also visualise the optic 
chiasma, central vessels and cavernous sinus.Over all signal characters depend on 
component of the tumour whether cystic hemorrahage or necrosis.T1 shows isointense to 
grey matter typically after heterogenous with larger lesion and due to areas cystic 
changes ,hemorrahage and necrosis that vary in signal.T1C +Gd (gadolinium )-solid 
component shows moderate to high enhancement .T2 isointense to grey matter typically 
.Heterogenesity after with larger lesions and vary with signal due cystic hemorrhage and 
necrosis.Calcification is rare and excluded with CT. 
T2 gradient with echo is more sensitive for delineation of hemorrhagic components with 
areas of signal loss . Pituitary macroadenomas preoperative evaluation of consistency 
with DW MRI
10
 the transnasal approach is contraindicated in tumour extension into 
1.sphenoid sinus; 2.ectactic midline carotid artery (kissing carotid) ;3.significant lateral 
suprasellar extension. 
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Based on tumour consistency -Most of the macroadenoma are easily resectable due to 
soft consis tency.Only 10% are fibrous and shows increase in consistency.Clinical 
Knowledge of macroadenoma consistency helps to plan the surgical technique well 
before the surgery properly.
11
Role of conventional MRI in relationship to consistency of 
macroadenoma is controversial.In one study macroadenoma of lower T2weighted signal 
intensity (SI) image shows enhancement more homogeneously with the mass are 
fibrosis/more collagen.
12
 Another study suggested that no particular correlation between 
MRI and tumour consistency.DW MRI measure diffusion of water and affected by the 
size and strength 
 of structures normally restricts brain diffusion.
13
 Tumour consistency at time of surgery 
blinded to DW MRI finding evaluated by neurosurgeon.Based on the apparent diffusion 
coefficient the tumours were classified on three groups -1.soft consistency tumour that 
are easily removable through suction ,2.intermediate consistency tumour that has 
difficulty in removal with suction 3.hard consistency that are not able to be removed by 
suction but by excision enbloc.
14 
DW imaging with generator of  apparent diffusion coefficient (ADC map useful method 
for prediction of consistency of pituitary macroadenomas with respect respectability of 
tumour with endoscopic technique.Mass arising from pituitary fossa that is hypointense 
on T1 MRI images and hyperintense and heterogenous in T2 weighted images.
15 
On conventional MRI tumour consistency and signal intensity on T2 weighted MRI 
shows soft tissue tumours displays lower SI than intermediate and hard groups.Fibrous 
tissue in macroadenoma with high cellularity with a nucleus to cytoplasm ratio is low 
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indicates lower signal intensity whereas extracellular space may cause larger increase in 
SI on T2 weighted MRI because of free increase in water.
16
 No relation between tumour 
consistency on SI T1 weighted MRI and contrast enhanced but cyst and haemorrhages 
are easily depicted by conventional MRI and easily found in Macroadenoma.
17,18 
DW MRI images provide information about consistency of macroadenoma during 
surgery more than 50% of macroadenoma which is softer consistency allowed complete 
removal through suction .Therefore the ADC  is relatively low.In intermediate 
consistency the ADC is slightly higher than the soft growth.In hard consistency solid 
tumours cannot be aspirated and excision done by enbloc.ADC significantly higher than 
those of intermediate and soft type of tumours. Therefore the preoperative detection of 
tumour check with DW MRI and ADC map as a relationship with tumour resectability. 
 In a study conducted by Alberto Pierallini   he reported the tumor consistency at surgery 
was soft in 12 (55%) patients, intermediate in six (27%) patients, and hard in four (18%) 
patients. In two patients, cystic components were evident with conventional MR imaging 
sequences and were confirmed at surgery. 
Of the twenty nine  patients, peroperative tumor consistency was classified as hard 
macroadenoma in 17% and soft macroadenoma in 83% of the cases according to J. 
Yamamoto etal.
19     
In the surgical management of pituitary macroadenomas the 
transsphenoidal approach has become the preferred operation because of its low 
morbidity and mortality.
21,22,23
 The factors determining a complete excision are cavernous 
sinus invasion, size and consistency of the tumor. Radical excision of the tumor with 
restoration of vision and preservation of pituitary function are the goals of surgery for 
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pituitary adenomas. The transsphenoidal approach fulfills these goals with minimal 
morbidity and mortality. 
23 
Hardy's classification of the suprasellar extension of pituitary adenomas  
Type-A Tumour with  sellar extension,not reaching the optic chaiasma 
Type-B Tumour reaches the floor of 3
rd
 ventricle obliterating the anterior recess of 3
rd
 
ventricle 
Type-C  Tumour indents the floor of 3
rd
 ventricle 
Type-D  Tumour with intradural extension 
Type-E Tumour invading the cavernous sinus  
“The grade A and B tumors were considered easier to excise while the removal of grade 
C and D tumors, those that had a superior margin more than 20 mm above the jugum 
sphenoidale, was more difficult (40% had residual tumor on the postoperative CT scan). 
The coronal images provided additional information regarding asymmetric lateral 
expansion of the tumor (grade D) that made a complete excision technically more 
difficult. Wilson's modification of Hardy's system
24
 introduced a 'stage E' when there was 
a direct lateral extension into the cavernous sinus and subsets to the 'stage D' when there 
was extension into the anterior, middle and posterior fossae.” 
The transsphenoidal surgical line of vision on a sagittal MRI is useful in assessing the 
ease of resectability of pituitary adenomas, especially in Grade C tumors. Depending on 
the clinical course, it may be possible to plan either a second stage transsphenoidal 
surgery or a craniotomy when more than 50% of the tumor is above the line of vision.
 
KNOSP classification of parasellar extension 
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Knosp et al
25
 offered a grading system for showing invasion of cavernous sinus by 
pituitary macroadenoma. Briefly, the much laterally adenoma grows and surrounds the 
ICA, the more grade level is. The grading defined by the relation of carotid lines with the 
limits of invasion. These lines passes through supra- and intra-cavernous parts of ICA in 
coronal view. There are medial, median and lateral carotid lines 
Grade 0 –Adenoma did not encroach the cavernous sinus space,not crossingthe medial 
aspect of intra and supra cavernous ICA 
Grade  1-   Tumour crosses medial tangent but does not extend beyond inter carotid line 
Grade  2-    Tumour crossed beyond intercarotid line but does not cross beyond lateral 
tangent of intra and supra cavernous ICA 
Grade- 3 -  Tumour extends beyond lateral line 
Grade-4-  Total encasement of  intra cavernous ICA by tumour 
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FIG-9 
KNOSP CLASSIFICATION OF PARASELLAR TUMOUR 
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FIG -10 
a) HARDY  CLASSIFICATION AND  b) KNOSP CLASSIFICATION 
 
 
 
 
36 
a) Hardy classification system. “ 
Sella turcica tumours can be 
        1.noninvasive :grade 0- intact with normal contour; grade I-intact with bulging floor;          
                                or grade II- intact, enlarged fossa or  
        2.invasive :grade III- localized sellar destruction; or grade IV-diffuse destruction.  
       Suprasellar tumours can be 
          1.symmetrical :grade A- suprasellar cistern only; grade B- recess of the third   
                                  ventricle;  or grade C- whole anterior third ventricle or  
          2. asymmetrical :grade D- intracranial extradural; or grade E- extracranial 
extradural (cavernous sinus). 
b) Knosp classification system used to quantify invasion of the cavernous sinus, in which 
only grades 3 and 4 define true invasion of the tumour into the cavernous sinus. Grade 0, 
no cavernous sinus involvement; grades 1 and 2, the tumour pushes into the medial wall 
of the cavernous sinus, but does not go beyond a hypothetical line extending between the 
centres of the two segments of the internal carotid artery (grade 1) or it goes beyond such 
a line, but without passing a line tangent to the lateral margins of the artery itself (grade 
2); grade 3, the tumour extends laterally to the internal carotid artery within the 
cavernous sinus; grade 4, total encasement of the intracavernous carotid artery. 
Recent  imaging techniques, especially  MRI , has high sensitivity in detecting 
aggressive pituitary tumors which are usually   macroadenomas, but currently there 
are no reliable features distinguishing aggressive from apparently „benign' adenomas 
in the series of atypical adenomas reported by Zada et al.
26 
Chatzellis E etal 
27
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described 94%  atypical adenomas  were macroadenomas, and radiological invasion 
was evident in 83% compared to 45% of typical adenomas (p = 0.004). Ten lesions 
(56%) showed infrasellar invasion with clival or sellar floor erosion, nine (50%) 
showed suprasellar invasion and six (33%) invaded at least one cavernous sinus; in 
five patients (28%), invasion of all three regions was noted.
 
Surgical techniques in complete excision 
Indications for surgery •Tumour  with mass effect(Macroadenoma: >1cm) –
Chiasmalcompression and objective visual field defect –Raised intracranial pressure 
•Pituitary dependant Cushing‟s disease •GH secreting tumour •Prolactinoma –Failure of 
medical of treatment –Intolerance of medical management –Pt preference •TSHoma –
Thyrotoxicosis 
Endoscopic assisted transphenoidal surgery 
This  procedure is performed using Hopkins rod  a  0 deg  telesscope, length of 18 cm and 
diameter  0.4 cm, as the sole visualizing instrument of the surgical field; sometimes 
angled scope are used to further explore the suprasellar area after the lesion removal. 
Appropriate surgical instruments with different angled tips are needed for permiting 
movements in all the visible corners of the surgical field.
28,29
 A thorough  preoperative 
planning by  three dimensional reconstructed   MRI and/or CT scans, is a road map of 
surgery. 
An image-guided system (neuronavigator) is needed when the classic landmarks are 
unidentifiable .  
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Bipolar endonasal foreceps  of different  diameters and lengths can be easily introduced 
and maneuvered in the nasal cavity,. High-speed lengthy low-profile drills are useful to 
open bony structures to reach  dural space.Finally, the important use of micro doppler 
probe to protect the major arteries .For increasing the work space and the handling of the 
instruments is achieved by  a)middle turbinate on one side to be removed; b)  
lateralization  
of the middle turbinate in the other nostril; and c)  removal of the posterior part of the 
nasal septum. An  anterior sphenoidotomy widely done. 
 
Positioning of the patient 
The patient is placed supinely or in slight Trendelenburg‟s position with turning of head 
10°–15° on the horizontal plane, towards the surgeon. The endoscopic equipment and the 
neuro image guiding system are placedbehind the head of the patient  
and in front of the surgeon.
30,31,32 
An altered combination endoscopic transseptal/transnasal binostril approach  in Patients 
with a   narrow Space in nasal cavity for pitiuitary lessions. This  uses a two-surgeon, 
four-handed technique  can provide a single, wide surgical field by a   combination of 
septoplasty and nasoseptal flap (NSF) harvestation,  that proved to be a genuine and 
acceptable method for that prevents postoperative cerebrospinal fluid (CSF) leakage
 
 
However, standard pituitary surgery does not usually require either the NSF or the two-
surgeon, four-handed technique. Meantime this technique not only provides dynamic 
endoscopic movement by an ENT(ear,,nose,,throat )surgeon, that offers  a clear and 
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pseudo-three dimensional visual area, but also allows manipulation of instruments which 
is smooth and comfortable.  
Modified Stamm's approach has  following advantages. 1) suitable for pituitary lesions 
associated with narrow nasal spaces  2) Handling  of instruments in and out through the 
transseptal route cannot be prevented by the nasal turbinates and/or septal mucosa, 3) the 
harvested flap can be used for sellar reconstruction in case of csf leak. Finally, it can 
collaterally improve patients' symptoms due to chronic nasosinusal diseases. The 
disavantages are time consumption for septal mucosa dissection and can lead to a septal 
perforation , transient dental pain or hyperesthesia. Nasal packing is done to prevent 
hematoma formation and promote mucosal healing, leading to patient suffering. The 
three different binostril approaches for the pituitary lesions are common binostril 
approach, original Stamm's approach and modified Stamm's approach. 
Transseptal-Transnasal 1. Killian incision 2.Bilateral flaps 3.Resect posterior septum 4. 
Elevate unilateral SN flap 5. Enter sphenoid as in transseptal approach 6. Advantages 
7.Two surgeon ability 8.SN flap reconstruction 9. Preserves contralateral mucosa 
Incision is made and through a minimal invasive  procedure endoscopically.Lengthy  
instruments are passed via the nostril while visualising the monitor. Nasal septum that 
divides the  left and right nostril is partly removed.The front wall of the sphenoid sinus is 
opened with the help of bone-biting instruments.  
Behind the posterior wall of sphenoid sinus is the bone overlying the pituitary gland, 
known as sella. The dura is exposed by removing  thin bone of the sella which exposes 
the tumor and pituitary gland .  
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The tumor is removed by the neurosurgeon / ENT surgeons via a small hole in the sella, 
in pieces with special instruments called curette,by coring out the from its centre all the 
tumor margins  were let to fall inward towards the reach of surgeon. Once all removal of 
visible tumor is done, the endosope is advanced  into the sella  for inspection of  hidden 
tumor.  
The sella floor closed by replacing with bone graft from the septum. Tissue  glue is 
applied over the graft in the sphenoid sinus.  
Peroperative photograph showing, (a) exposed sphenoid sinus and of sellar floor (SF), 
tuberculum sellae (TS), planum sphenoidale (PS), lateral and medial carotid recesses, 
optic and carotid prominences, and clivus (b)dural exposure of SF, TS, and PS with 
superior intercavernous sinus (c)  sellar cavity tumour  , and (d) covering suprasellar part 
of the tumor with its pseudocapsule and arachnoid . (e) endosellar or extraarachnoid 
approach for intracapsular removal of intrasellar pituitary adenoma (f) intraarachnoid or 
extracapsular removal of suprasellar adenoma (g and h) panoramic (g) and focus view (h) 
views of the operative areas after complete tumor removal. 
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FIG -11 
 
ENDOSCOPIC TRANS SPHENOIDAL EXCISION OF PITUITARY   
MACROADENOMA PER OPERATIVELY 
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Endoscopic transsphenoidal approach has evolved considerably in the last 10-15 years 
and is now the commonly used surgical procedure for most pituitary adenomas. Recent 
studies with this approach have shown increased tumor resection rates with minimal 
complications . However, certain adenomas, such as those with dumbbell configuration, 
firm or fibrous consistency, or pure suprasellar components, and some large recurrent 
tumors are difficult to remove by the conventional endoscopic approach. As a result, 
alternative surgical procedures like staged-transsphenoidal, transcranial, or combination 
of transsphenoidal-transcranial approaches having been used for management of these 
subtypes of pituitary tumors. With growing experience in the endoscopic surgery for 
various skull base lesions, it has now become possible to remove a wide variety of 
anterior and middle fossa tumors safely and more effectively. 
The advantages of EEEA are many and are mainly because of the wider exposure that it 
provides after removal of SF and the bone of the TS and PS. The intradural exposure 
achieved by this approach offers a simultaneous and direct endosellar and 
extraarachnoidal (intracapsular) access to the tumor in the sellar region, and a suprasellar 
and intraarachnoidal (extracapsular) access to the suprasellar part of the tumor. The 
intracapsular tumor removal is carried out via the endosellar route, and using the 
suprasellar corridor at the same time, the tumor capsule is dissected from overlying 
suprasellar cistern, OPs and chiasm, and the anterior cerebral arteries under direct vision. 
The basic technique of pituitary macroadenoma surgery involves tumor removal by 
curettage and suction method. Although it works well for the majority of pituitary 
tumors, the maneuver is totally ineffective when the tumor is firm and fibrosed. A blind 
 
43 
curettage to remove suprasellar mass from the endosellar route has been found potentially 
dangerous and is associated with a high incidence of incomplete tumor removal from the 
suprasellar region. The standard transsphenoidal surgery for pituitary adenomas also 
relies mainly on spontaneous descent of the suprasellar portion of tumor into sellar cavity 
after initial tumor debulking by endosellar route.Occasionally, the suprasellar tumor does 
not fall into the sella and causes a large tumor mass to remain in the suprasellar region as 
a residue. The EEEA provides different corridors, endosellar and suprasellar, to dissect 
the tumor safely from the surrounding structures under direct vision. It also provides 
direct visualization and accessibility to suprasellar, subchiasmal, retrochiasmal, and 
retrosellar regions which are generally poorly visible in the standard transsphenoidal 
surgery. 
In cases of dumbbell tumors, a narrow diaphragma opening prevents descent of the 
suprasellar portion of tumor into the sellar cavity. The fibrous tumors, recurrent tumors 
after initial surgery or irradiation, and some medically treated large tumors fail to fall into 
the sellar cavity because of their firm consistency and are, therefore, less likely to be 
removed totally by the routine transsphenoidal route. The EEEA is advantageous in these 
cases because it offers larger tumor exposures through two different routes, endosellar or 
extraarchnoidal, and suprasellar or intraarachnoidal, which facilitates entire tumor 
removal in a single-stage surgery. Purely suprasellar tumors and some giant tumors with 
large midline extensions in the subfrontal regions are not adequately visualized via the 
endosellar route and are, therefore, clearly unsuitable for the standard transsphenoidal 
approach. By adding a transtubercular-transplanum extension to the regular 
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transsphenoidal endosellar approach, the possibility of tumor removal from these areas 
can be increased considerably. Both patients in our series with primary suprasellar 
residual tumors and one of the two patients, who had giant pituitary tumors with large 
subfrontal extensions, had a complete resection of their adenomas. 
 
After endoscopic surgery duration for hospital stay is for  one or two  days. During this 
period, nurses will change dressings and  helps the patient in bathroom needs. Patient  
will be able to return to a normal diet as long as they take fluids well. Patients are 
encouraged to get out of bed and walk as soon as they are able. While in the hospital, 
patient will be asked to help your nurses keep track of the amount of fluids they drink and 
their urine output to evaluate pituitary function. 
Home care may include: 
  Analgesics to control headaches, the most common complaint after surgery 
  Lifting weights or straining for stools are allowed until clear advice given by the 
doctors. 
 Follow-up visits with your endocrinologist and surgeons 
 MRI  has to be repeated 
  Eye testing 
 It is important to let your doctors know about: 
 Any headache that doesn't go away with medication 
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 Nausea and vomiting 
 Fever 
 epistaxis 
 Watery discharge from the nose 
 Increase in frequency of urination 
At first Jankowski
33
 and his colleagues reported tumour removed successfully  via 
endoscopy in 3 pituitary adenomas.” “Further on,many more  surgeons committed 
themselves to endoscopic transphenoidal pituitary surgery. Many successful cases were 
also reported in China.”34,35 
In a study by Yun-ping Fan etal  
36
 total resection was demonstrated in 16 patients; 
subtotal resection (the extent of removal was greater than 90%) was in 8 patients; partial 
resection was in 3 patients. Only biopsy was done in one patient (GH secreting tumor) 
owing to unexpected excessive bleeding intra-operatively and hard quality of the tumor. 
Among 3 cases with partial resection, 2 had tumor growth seen on CT in the 6 months 
follow-up period; one resorted to radiotherapy, but the other refused and eventually lost 
to follow-up.  
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Junko et al  
37
 reported that transsphenoidal approach is safe procedure even in giant 
pituitary adenomas, as it allows rapid and appropriate decompression of the optic nerves 
and chiasm with low morbidity rates.
 
Peroperative and postoperative complications and their management  
General complications are due to haemorrhage, infection and anesthesia. Specific 
complications are 
Visual loss- peroperative damage to optic chiasm can be damaged during surgery. If 
vision problems existed preoperatively, decompression may not restore normal vision. 
The nerve would  have been permanently damaged by the tumor. 
 Pituitary gland damage- Hormone are given post operatively. 
 diabetes insipidus (DI): neurohypophysis damage. DI leads to polyuria and polydipsia 
because the kidneys inability to concentrate the urine and is mostly temporary, lasting 1 
to 3 days. Desmopressin acetate (DDAVP) in nasal spray or pillform are used for 
control of DI .  
 cerebrospinal fluid (CSF) rhinorrhea : identified as wash out sign.treated with multiple 
layer of patching. 
 meningeal irritation 
 CVA- due to peroperative injury of carotid and cavernous sinus  leading to  decreased 
blood supply to the brain. 
 Nasal congestion 
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 Epistaxis 
 Nasal deformity 
 
According to Yadav  etal 
38
   no intraoperative csf leak but higher incidence of post 
operative csf leak in the endoscopic group was because of large lesions with higher 
proportions of suprasellar tumors and also due to initial learning curve but Leng Lz etal  
39
  repoted low CSF leak in the endoscopic group. 
Gondim et al 
40
 observed 26.9% complications in their series. Post-operative CSF leaks-
2.6%,     delayed nasal bleeding-1.9% ,  sphenoid sinusitis -1.6%, carotid artery injury-
0.9%  , and meningitis occurred in 0.6%.Endocrinological complications were observed 
in 17.9% cases out of which anterior lobe insufficiency was seen in 11.6% and diabetes 
insipidus in 6.3% cases. Nasal complications occurred in 29.6% of the operated cases 
according to Yadav etal According to Mirian Cabral Morieade Castero etal no nasal 
complications  observed. 
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MATERIALS AND METHODOLOGY 
                      
 
 
           The study was conducted in Rajiv Gandhi Government General Hospital 
and Madras Medical College in the Upgraded Institute Of Oto-Rhino-
Laryngology ,Chennai  from June 2015 to  September 2016 . The study was a 
retrospective and prospective study .The study population comprised of patients 
who were diagnosed to have pituitary macroadenoma..Cases of pituitary 
macroadenoma attending neurology opd ,surgical endocrinology opd and cases 
referred from these opd’s  to Upgraded Institute of Otorhinolaryngology, Rajiv 
Gandhi Government General Hospital, who satisfy the inclusion criteria were 
studied.The inclusion criterias- for selection of the study group were all cases fit 
for surgery  ,newly diagnosed cases  and recurrent cases.The exclusion criterias 
were the cases of extreme age groups and  poor general conditions and cases 
having comorbid conditions that are not fit for surgery. The sample size for this 
study was 28 .CT scan and MRI was done. Instituitional Ethical clearance and 
informed consent was obtained . 
Data  regarding  patient age ,sex ,type of tumour, modes of presentation , tumour 
consistency ,tumour intensity and tumour extension based on MRI T2 weighted 
images, peroperative findings, tumour excision, peroperative complications, post 
operative complications ,management of complications and post operative 
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recurrences was collected.data was entered as codes  in excel sheet and analysis 
was done using statistical software EPI INFO version 7 . 
Descriptive statistics  like  mean ,standard deviation and proportion were used to 
express the  study characteristics.Chi square test was used to find association 
between the MRI T2 weighted images based consistency and tumour extension  
with surgical.Implication.A p-value <0.05 was considered as significant. 
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RESULTS AND OBSERVATIONS 
 
          A total number of 28 cases were studied.The details of all the cases are given in the 
master chart.the following observations were made and analysed. The age range of the 
study population was from from 24 to 58 years.Their mean age of the was 40.39 years 
and standard deviation 10.76. 
 TABLE  1 :AGE DISTRIBUTION OF STUDY POPULATION 
 
AGE IN YEARS NUMBER OF INDIVIDUALS PERCENTAGE 
20-30 07 25.00% 
             31-40 07 25.00% 
41-50 09 32.14% 
51-60 05 17.86% 
TOTAL 28 100.00% 
 
 
 
FIG-12 
Majority of the pituitary macroadenomas were seen in the age group 41-50 year(32.14%). 
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  TABLE 2 :SEX DISTRIBUTION OF THE STUDY POPULATION 
 
SEX NUMBER OF INDIVIDUALS PERCENT 
MALE 13 46.4% 
FEMALE 15 53.6% 
TOTAL 28 100.00% 
 
 
 
 
 
   
FIG-13 
 
The total number of females were 15 (53.6%) and males were 13(46.4%). 
  
46.4% 
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TABLE 3: TYPE OF PITUITARY MACROADENOMA 
 
TYPE OF PITUITARY 
MACROADENOMA 
NUMBER OF 
INDIVIDUALS 
PERCENT 
SECRETORY  11 39.3% 
NON SECRETORY 17 60.7% 
TOTAL 28 100.00% 
 
 
 
FIG-14 
 
 
All the pituitary macroadenomas were divided into non secretory and secretory group. 
Among   the 28,  nonsecretory were 17(60.7%)  and secretory were 11(39.3%).  
 
 
 
 
 
 
 
 
39.3% 
60.7% 
TYPE OF PITUITARY MACROADENOMA 
SECRETORY NON SECRETORY
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TABLE 4:Age Wise Distribution Of Types Of Pituitary Macroadenoma 
 
  Among the secretory type and non secretory type of tumour majority were present in the 
age groups 20-30 years and 51-60 years respectively.  
 TABLE 5:SEX WISE DISTRIBUTION OF TYPES OF PITUITARY  
 
 
   Secretory type of tumours were more predominant in males (53.8%)  and nonsecretory 
type of    tumours were predominant in females 11(73.3%). 
  TYPE OF PITUITARY MACROADENOMA   
AGE GROUPS IN 
YEARS 
SECRETORY 
N(%) 
NON SECRETORY 
N(%) 
TOTAL(%) 
20-30 5(71.4) 2(28.6) 7(100) 
31-40 2(28.5) 5(71.4) 7(100) 
41-50 3(33.3) 6(66.7) 9(100) 
51-60 1(20.0) 4(80.0) 5(100) 
TOTAL(%) 11(39.3) 17(60.7) 28(100) 
  TYPE OF PITUITARY MACROADENOMA   
SEX 
SECRETORY 
N(%) 
NON SECRETORY 
N(%) 
TOTAL 
MALE 7(53.8) 6(46.1) 13 (100.00%) 
FEMALE 4(26.7) 11(73.3) 15 (100.00%) 
TOTAL 11(39.3) 17(60.7)  (100.00%) 
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TABLE 6:NEW / RECURRENT CASES 
 
NEW /RECURRENT 
CASES 
NUMBER OF 
INDIVIDUAL 
PERCENTAGE 
RECURRENT CASES 3 10.7% 
NEW CASES 25 89.3% 
TOTAL 28 100.00% 
 
 
 
 
 
 
FIG-15 
Among the study population  25 (89.3%) were new cases and 3 were recurrent 
cases(10.7%) 
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TABLE 7: MODES OF PRESENTATION OF PITUITARY MACROADENOMA 
 
 
*multiple response 
 
 
 
 
FIG-16 
In our study the predominant symptoms were headache (71.4%) and visual defects 
(42.8%).Out of 5 cases of prolactinoma 3 cases presented with galactorrhoea and 2 cases 
presened with gynaecomastia and loss of libido. 2 cases presented with head ache and 
galactorrhoea ,5 cases presented with head ache and acromegaly,5 cases presented with 
head ache and visual defects and 1 case presented with head ache, galactorrhoea,visual 
defect and apoplexy. 
20 
5 
1 
12 
5 
1 
0 5 10 15 20 25
HEAD ACHE
PROLACTINOMA
APOPLEXY
VISUAL DEFECTS
ACROMEGALY
CUSHINGS SYNDROME
NUMBER OF INDIVIDUALS 
MODES OF PRESENTATION 
MODES OF PRESENTATION* 
NUMBER OF INDIVIDUAL 
N=28 
PERCENTAGE 
 
HEAD ACHE 20 71.4% 
PROLACTINOMA 05 17.8% 
APOPLEXY 01 3.5% 
VISUAL DEFECTS 12 42.8% 
ACROMEGALY 05 17.8% 
CUSHINGS SYNDROME 01 3.5% 
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TABLE 8:TUMOUR CONSISTENCY BASED ON MRI  WEIGHTED IMAGES 
 
TUMOUR CONSISTENCY NUMBER OF 
INDIVIDUAL 
PERCENTAGE 
CYSTIC 5 17.9% 
SEMISOLID 10 35.7% 
SOLID 13 46.4% 
TOTAL 28 100.00% 
 
 
 
FIG-17 
 
MRI weighted images showed  46.4% ,35.7% and 17.9% of the tumours were solid 
,semisolid and cystic respectively. 
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TABLE 9: TUMOUR EXTENSION BASED ON MRI WEIGHTED IMAGES 
 
TUMOUR EXTENSION 
 
NUMBER OF 
INDIVIDUAL 
(N=25) 
PERCENTAGE 
 
SELLAR  03 10.7% 
SUPRASELLAR  14 50.00% 
SELLAR AND PARASELLAR 04 14.3% 
SUPRASELLAR AND 
PARASELLAR 07 25.00% 
TOTAL 28 100.00% 
 
 
 
 
FIG-18 
Majority  of tumour extension was to the suprasellar region (50%)  and in 25% the 
tumour extension was seen in both suprasellar and parasellar region.Tumour was limited 
to sellar region in 3 cases (10.7%) 
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 TABLE 10: SURGICAL IMPLICATION OF CONSISTENCY  BASED ON MRI  WI 
 
 
 
FIG-19 
On MRI based images , consistency of 10 tumours were semisolid of which on 
peroperative findings 6(60%)were soft and 4(40%) were firm. 92.3% of the tumours 
having solid consistency on MRI  weighted based images were firm and the remaining 
7.6%% were found to be soft on per operative finding. Cystic consistency based on MRI 
images were similar with the peroperative findings.Cystic tumours were removed by 
suction. 
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SURGICAL IMPLICATION OF CONSISTENCY  BASED ON  
MRI   WI 
 
CYSTIC SOLID SEMISOLID
  
TUMOUR CONSISTENCY PER 
OPERATIVE 
  
Chi 
squre 
P 
value 
CONSISTENCY 
BASED ON MRI 
CYSTIC FIRM SOFT Total 
value  
SEMISOLID 0(0.0%) 4(40.0%) 6(60.0%) 10(100.0%)   
SOLID 0(0.0%) 12(92.31%) 1(7.69%) 13(100.00%) 36.89 <0.05 
CYSTIC 5(100.0%) 0(0.0%) 0(0.0%) 5(100.0%) 
 (signif
icant) 
TOTAL 5(17.8%) 16(57.1%) 7(25.0%) 28(100.0%)   
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TABLE 11 :SURGICAL IMPLICATION OF TUMOUR EXTENSION BASED ON 
MRI WI 
 
FIG-20 
 
Suprasellar extension on MRI was s similar in 12 cases peroperatively and 2 cases 
showed extension of tumour laterally (parasellar) without carotid encasement or 
cavernous sinus invasion.Suprasellar and parasellar extension on MRI were similar only 
in  5 cases whereas  2 cases were not similar with the peroperative findings.  
  
TUMOUR  
EXTENSION -PER 
OPERATIVE 
  
  
TUMOUR 
EXTENSION ON MRI  
SIMILAR 
NOT 
SIMILAR 
Total 
Chisquare 
value 
P value 
SELLAR 3(100%) 0(0.0%) 3(100.0%)   
SUPRASELLAR 12(85.7%) 2(14.2%) 14(100.0%)   
SELLAR AND 
PARASELLAR 
4(100.0%) 0(0.0%) 4(100.0%) 
2.333 0.506 
SUPRASELLAR AND 
PARASELLAR 
5(71.4%) 2(28.5%) 7(100.0%) 
        (not 
significant) 
TOTAL 24(85.7%) 4(14.2%) 28(100.0%)   
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TABLE 12: TUMOUR EXCISION 
TUMOUR EXCISION 
 
NUMBER OF 
INDIVIDUAL 
PERCENTAGE 
COMPLETE  21 75.00% 
INCOMPLETE 7 25.00% 
TOTAL 28 100.00% 
 
 
 
 
FIG-21 
Complete excision was done in75% of the cases and the remaining 25% was incomplete 
excision of the tumour . 
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TABLE 13: PEROPERATIVE COMPLICATION 
 
PEROPERATIVE 
COMPLICATION 
 
NUMBER OF 
INDIVIDUAL 
PERCENTAGE 
NIL  22 78.57% 
CSF LEAK 6 21.43% 
TOTAL 28 100.00% 
 
 
 
FIG-22 
 
  CSF leak was the only  peroperative complication found  in 6 cases(21.4%). 
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TABLE 14: POST OPERATIVE COMPLICATION 
POST OPERATIVE 
COMPLICATION* 
 
 
NUMBER OF 
INDIVIDUAL  
N=28 
PERCENTAGE 
NIL 20 71.400% 
DIABETES INSIPIDUS 3 42.8.00% 
PNEUMOENCEPHALOCOEL 1 3.5% 
CVA 2 7.1% 
CSF LEAK 1 14.2% 
*multiple response. 
 
 
 
FIG- 23 
 
The most common post operative complication was diabetes insipidus in 3 cases  .In one 
case pneumoencephalocoel along with CSF leak and in another case CVA with diabetes 
insipidus  was noted. 
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TABLE 15:MANAGEMENT OF COMPLICATIONS 
MANAGEMENT OF 
COMPLICATIONS* 
NUMBER OF 
INDIVIDUAL  
N=28 
PERCENTAGE 
NIL 17 60.7% 
CSF LEAK REPAIR 7 25.0% 
DESMOPRESSIN 3 10.7% 
CVA CONSERVATIVE 
MGMT 2 7.1% 
LUMBAR DRAIN 1 3.5% 
*multiple response. 
 
 
FIG-24 
Peroperative CSF leak repair was  done for 6 cases and for 1 case post operative  CSF 
leak  repair done and lumbar drain was kept. Post operative diabetes insipidus was treated 
with intranasal desmopressin in 3 cases.CVA was managed conservatively in 2 cases. 
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TABLE 16: RELATIONSHIP  BETWEEN TUMOUR EXTENSION AND HEAD 
ACHE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG-25 
 
 
Among 14 cases with  suprasellar  extension 10(71.4%) presented with head ache and all 
4 cases with sellar and parasellar extension presented with headache. 
 
 
 
 
  HEAD ACHE   
TUMOUR EXTENSION ON MRI  PRESENT ABSENT TOTAL 
SELLAR 2(66.6%) 1(33.3%) 3(100.00%) 
SUPRASELLAR 10(71.4%) 4(28.5%) 14(100.00%) 
SELLAR AND PARASELLAR 4(100.0%) 0(0.0%) 4(100.00%) 
SUPRASELLAR AND PARASELLAR 4(57.1%) 3(42.8%) 7(100.00%) 
TOTAL 20(71.4%) 8(28.5%) 28((100.00%) 
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TABLES 17: RELATIONSHIP  BETWEEN TUMOUR EXTENSION AND 
VISUAL DEFECT. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 FIG-26 
 
Visual defects were present in 5(71.4%) cases among the 7 cases having sellar and 
parasellar extension. 
  VISUAL DEFECT   
TUMOUR EXTENSION ON MRI  PRESENT ABSENT TOTAL 
SELLAR 0(0%) 3(100%) 3(100%) 
SUPRASELLAR 6(42.8%) 8(57.1%) 14(100%) 
SELLAR AND PARASELLAR 1(25.0%) 3(75.0%) 4(100%) 
SUPRASELLAR AND PARASELLAR 5(71.4%) 2(28.5%) 7(100%) 
TOTAL 12(42.8%) 16(57.1)% 28(100%) 
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MRI – SUPRASELLAR EXTENSION 
 
FIG-27 
The enlarged lesion starts in the sella,and extends into the suprasellar cistern.  
 The classic dumbbell shaped (snowman appearance) observed is caused by constriction 
by the diaphragma sellae. The blood-fluid level  indicates hemorrhage. 
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MRI – SELLAR AND PARASELLAR 
 
 
 
 
FIG -28 
Pituitary macroadenoma with bilateral cavernous sinus extension with hemorrhagic foci . 
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MRI – SUPRASELLAR AND PARASELLAR 
 
 
 
FIG -29 
 
A large suprasellar mass compresses optic chiasma and optic nerves causing significant 
mass effect and mild extension towards cavernous sinus. 
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MRI – RECURRENT/RESIDUAL PITUITARYMACROADENOMA 
 
  
 
FIG-30 
 
 
Well defined isointense mass causing compression of optic chiasma and lateral 
displacement of cavernous segment of bilateral internal carotid artery. 
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MRI – PITUITARY APOPLEXY 
 
 
 
 
FIG -31 
 
MRI Sella with contrast- pituitary appears enlarged .The posterior pituitary hyperintense 
lesion with central hypointensity and anterior pituitary appears isointense.On IV contrast 
lesion shows peripheral enhancement with central non enhancing component. 
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FIG -32 
A CASE OF PITUITARY MACROADENOMA WITH ACROMEGALY 
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FIG -33: MRI – BEFORE SURGERY  
 
 
FIG -34: MRI – AFTER SURGERY 
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DISCUSSION 
 
           The present study was undertaken on 28 patients who sought treatment in 
department of ENT ,Rajiv Gandhi government hospital and Madras Medical College. 
            In our  study the  mean age of the study population was 40.39 years and standard  
10.76.Majority of the pituitary macroadenomas were seen in the age group 41-50 
year(32.14%). Cawich S et al
41
 found in his study the mean age was  45.4 years (SD +/-
14.8).The females constituted 60% and males 40% in our study which was similar to a 
study conducted by Cawich S et al.
41 
 
            Non secretory type of pituitary macroadenomas were predominant (60.7%) than 
the secretory type(39.3%) in our study .According to Cawich S et al 55% were non 
secretory and 44.4% were secretory type .Castro
  
MC
6
 et al in his study found non-
secreting type in 96 (74.42%) and secreting in 33 patients (22.58%).In our study the 
predominant symptoms were headache (71.4%) and visual defects (42.8%) whereas 
Cawich et al
41
 reported visual defects as the predominant symptom followed by 
headache. Castro MC etal 
6
 reported acromegaly and galactorrhoea in their study while  
Junko
37
 in his study found visual defects as predominant symptom followed by head ache 
, galactorrhoea and acromegaly. 
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TABLE 18:COMPARATIVE STUDIES ON MODES OF PRESENTATION 
 
Modes Of  Presentation 
 
 
Castro
  
MC 
et al (6) 
 
 
Cawich S et al   
(41) 
 
 
Junko et al 
(37) 
 
Our Study 
 Head Ache - 72.3% 12.8% 71.4% 
Galactorrhoea 6.9% 19.3% 18.0% 10.7% 
Apoplexy - 05% - 3.5% 
Visual Defects - 80.7% 71.7% 42.8% 
Acromegaly 7.6% - 5.1% 3.5% 
Cranial Nerve Palsy - 16% - - 
Amenorrhoea - 26% - - 
 
Signal Intensity of MRI based on T2 weighted images was 40% hyperintense,33% 
isointense and 27% hypointense according Heck A et al . 
42 
Yamato et al
19
 reported 62 .06% tumours were solid and 37.93% semisolid in a 
comparative study of solid and semisolid types of pituitary macroadenoma. In contrast 
our study found 60% were semi solid and 40% were solid tumours. Out of 15 semisolid 
tumour  on MRI T2 WI  13 were soft and 2 cases hard peroperatively and among 14 solid 
tumour on MRI T2 WI only 3 were found to be hard and the remaining 11 were soft per 
operatively according to Yamato et al and he also found that there was no  significant 
correlation between tumor consistency at the time of surgery and T2WI . 
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On MRI based images , consistency of 10 tumours were semisolid of which on 
peroperative findings 6(60%)were soft and 4(40%) were firm. 92.3% of the tumours 
having solid consistency on MRI  weighted based images were firm and the remaining 
7.6%% were found to be soft on per operative finding. Cystic consistency based on MRI 
images were similar with the peroperative findings. 
Ramakrishnan VR
43
 in his study found that of the 106 patients included in the study, 
seventy one (67%) showed suprasellar extension of their tumor. Various studies revealed  
parasellar invasion by a pituitary adenoma is clinically significant and occurs in 6 to 10% 
of cases.
44 
Majority  of tumour extension was to the suprasellar region (50%)  and in 25% the 
tumour extension was seen in both suprasellar and parasellar region. Suprasellar 
extension on MRI was  similar in 12 cases peroperatively and 2 cases showed extension 
of tumour laterally (parasellar) without carotid encasement or cavernous sinus invasion. 
Suprasellar and parasellar extension on MRI were similar only in  5 cases whereas  2 
cases were not similar with the peroperative findings.  
The assessment of parasellar extension of a macroadenoma is important  in the evaluation 
of the preoperative MRI study. There are few indicators of parasellar involvement, since 
clinical features occur late and subsequent examination of both histologic and molecular 
tumor markers is inconsistently correlated with parasellar invasion. 
45 
According to Hardys‟  classification the grade A and B tumors were considered easier to 
excise while the removal of grade C and D tumors, those that had a superior margin more 
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than 20 mm above the jugum sphenoidale, was more difficult (40% had residual tumor on 
the postoperative CT scan). 
Knosp et al offered a grading system for showing invasion of cavernous sinus by pituitary 
macroadenoma. Briefly, the much laterally adenoma grows and surrounds the ICA, the 
more grade level is. The grading defined by the relation of carotid lines with the limits of 
invasion. 
Thereby enmasse dissection is possible only when tumour lies with minimal or no 
suprasellar extension and also lies between the carotid. 
Arbolay Omar
7
 in his study noted gross removal of tumour is seen in 92.4%  and subtotal 
resection in 7.8%.  by endonasal endoscopic trans sphenoidal surgery. 
 Fan YP etal 
36
  reported among 28 patients ,total resection was done  in 16 patients , 
subtotal resection (the extent of removal was > 90%)  in 8 patients , partial resection  in 3 
patients and biopsy in 1 due to excessive bleeding and hard nature. 
Complete excision was done in75% of the cases and the remaining 25% was incomplete 
excision of the tumour  . Among the incompletely removed 5 cases  underwent subtotal 
removal and 2 cases  partial removal. Complete resection is done in all cases where there 
is proper plane of dissection with  no or minimal suprasellar extension and enmasse 
resection is also possible only when tumour lies with in the carotid . Intra operative 
carotid doppler monitoring had been used that prevents from encountering the carotid 
artery . Incomplete excision was done in 7 cases of which subtotal resection was done 
(>90% of tumour removed) in 5 cases. Among these 5  cases in which subtotal resection 
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was done , in  three cases extension was found to suprasellar and parasellar region 
involving right cavernous sinus with further extension into the sphenoid sinus while in 
other two cases  the tumour had  suprasellar extension with encasement of carotid 
laterally. One among these two cases which encased carotid laterally had galactorrhoea 
who developed pituitary apoplexy leading to sudden headache and  ,visual defects along 
with galactorrhoea. This  patient was taken for surgery immediately  and per operatively 
blood clotted sellar could not be identified easily . These 5  tumours were found to be  
very hard in consistency and was  removed in piece meal. 
In our study CSF leak was the only  peroperative complication found  in 6cases (21.4%) 
and the most common post operative complication noted  was diabetes insipidus in 3 
cases  .In one case pneumoencephalocoel along with CSF leak and in another case CVA 
with diabetes insipidus  was noted. 
Castro
  
MC et al
6
  found the main complication found in patients were  CSF fistulas in 
8.5%,meningitis in 3.1% and one death due to major intracerebral hemorrhage in the 
postoperative period. 
As complications ,transient diabetes insipidus in 13 cases(33.3%), cerebrospinal fluid 
leakage in 3 cases(7.7%), subarachnoid hemorrhage in 1 case (2.6%) were observed by 
Junko et al.
37
  
The low rate of complications depends on several factors such as the extension of the 
tumoral resection, the type of tumor, and the preservation of the structures around the 
injury (hypophysis, cavernous sinus, suprasellar space). 
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Junko et al
37
 in his study observed CSF fistulas, that occurred in eleven patients were 
cured by conservative treatment in seven cases (5.53%), and four  patients (3.1%) were 
reoperated through the endoscopic approach to close the fistula. Meningitis  complication 
was managed with antibiotics therapy. 
In our study peroperative CSF leak repair was  done for 6 cases by multilayer  closure  
done by sealing with fat, cartilage ,naso septal flap , surgicell and tissue glue followed by  
nasal packing done with meurocell  and kept insitu for one week.The post operative 
period was uneventful and pack was removed after a week and by doing diagnostic nasal 
endoscopy in our operation theatre under aseptic condition no leak was observed in those 
cases. For 1 case, which was a recurrent case, after incomplete removal of the tumour 
patient developed csf rhinorrhoea on second post operative day followed by which patient 
developed pneumoencephalocoel that manifested as severe head ache ,vomiting and 
giddiness .The patient was on higher antibiotics ,osmotic diuresis and anti seizure drugs 
.The patient was kept in Fowlers position at 30 degrees and lumbar drain was kept for a 
week.CSF leak stopped and symptoms of pneumoencephalocoel subsided.This was 
followed by subsequent surgery for closure of the defect.  Post operative  period was 
uneventful. Post operative diabetes insipidus  presented with polyuria , nocturia and 
polydipsia abruptly with in first 24-48 hours of surgery  in 3 cases .Thirst was prominent 
and constant symptom. The biochemical analysis of post operative diabetes insipidus was 
established by increased osmolarity and hypernatremia in the presence of hyposmolar 
urine .Urine specific gravity was checked routinely every 12 hours and urine output was 
carefully monitored. Fluid replacement was done based on input output chart where input 
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is increased to that of the output loss and patient was with manifestation was treated with 
oral and intranasal desmopressin. All these  3 patients improved well with in a week to 10 
days.  
Two  cases who had hypertension as comorbid condition developed cerebro vascular 
accident (CVA )post operatively due to persistent elevation of blood pressure leading to 
anterior cerbral artery infarction.CVA was perse not due to surgical intervention as 
carotid artery was monitored with carotid Doppler preoperatively. CVA was managed 
conservatively.  
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CONCLUSION 
 
In our study pituitary macroadenoma is predominant in 5
th
 decade.Non secretory tumours 
are more than secretory tumours  with female preponderance but secretory tumours are 
common in male. 
Headache is common and early symptom that to with  suprasellar extension  followed  by    
visual defects. In sellar tumours the manifestations are less common. 
Among secretory macroadenoma acromegaly is most common manifestation followed by 
prolactinoma and least is ACTH producing tumour. 
MRI is a reasonable tool to predict the consistency of pituitary macroadenoma.T2 
weighted MRI that is hyperintense without contrast   characterizes the nature of the 
tumour. 
The transsphenoidal endoscopic surgical approach is adequate for total removal of 
pituitary macroadenoma with cystic and soft consistency.A  well formed circumscribed 
capsule confined to sella allows for extracapsuler centrepetal dissection which leads to 
total resection  of macro adenoma. 
In solid tumours with extensive suprasellar extension and parasellar encasement of 
carotids,the trans sphenoidal endoscopic approach may not be adequate for complete 
resection. 
The incidence of per operative  complications like csf leak, haemorrhage and post 
operative diabetes insipidus is very less if meticulous dissection technique is carried out 
with tissue respect and minimal injury. 
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 ANNEXURES 
 
PROFORMA 
 
 
Serial number                                      MRD NO:                                  IP/OP NUMBER: 
 
Name:                                   Age:                                                  Sex:  
 
Address                                                                                             
 
Occupation                                                                                  Income: 
 
Chief complaints: 
 
History of presenting illness: 
 
            1. head ache               2.galactorrhoea        3. acromegaly      4. visual defects 
 
            5.vomiting      6. cushingoid features     7.impotence   8.loss of libido              
                                           
            8.any history of ear ,nose ,throat symptoms                                                        
 
Past history: h/o diabetes mellitus ,hypertension ,TB,Asthma ,epilepsy , 
                     h/o irradiation for similar disease,h/o previous surgery 
 
Family history:  h/o similar history among family members 
 
Personal history:     h/o smoking ,alcohol,  
                                  dietary habits,  
CLINICAL EXAMINATION 
 General examination-conciousness ,orientation,built  
                                    Pallor ,icterus  ,cyanosis ,clubbing ,oedema , 
                             Vitals :pulse ,blood pressure ,temperature ,respiratory rate 
                             Anthropometry:height ,weight 
 Systemic examination 
    1.central nervous system:level of consciousness 
                                             Higher functions 
                                             Signs of meningeal irritation                                         
 
                                                  Cranial nerve tests:olfactory ,optic ,occulomotor 
,trochlear,trigerminal,abducent, facial ,vestibulocochlear ,glossopharyngeal ,vagus 
, cranial spinal accessory  and  hypoglossal. 
  
       2.Respiratory system 
      3. Cardiovascular system 
       4.Gastrointestinal system 
Local examination 
Ear nose throat examination: 
 Ear –                                        Right                                           Left 
Pinna 
Preauricular region 
Post auricular region 
Tragal tenderness 
External auditory canal 
Tympanic membrane 
Mastoid tenderness 
Facial nerve 
Fistula sign 
Tuning fork test 
         Rinnie 
         Weber  
         ABC 
Vestibular and cerebellar function test 
Nose  :external contour 
           Anterior nasal examination 
          Paranasal sinus tenderness 
          Post nasal examination  
Throat 
      Oral cavity 
      Oropharynx 
      Indirect Laryngoscopy 
 
Neck  
 
Investigation: 
 
MRI : 
        Size of the tumour : 
 
        consistency of tumour- 1.semisolid  2.solid    3.cystic   
 
        intensity  of the tumour-1.hyperintense  2.hypointense 3.isointense 
 
        Extension of tumour - 1.Sellar 2.suprasellar 3.sellar parasellar  
  
                                                  4.suprasellar and  parasellar 
 
 
 PER OPERATIVE FINDING: 
 
                                 Consistency : 1.soft   2.firm     3.cystic 
 
                                 Extension of tumour :1.similar  to MRI findings 2.not similar to                
                                                                          MRI findings 
 
                                 Tumour excision- 1.complete 2.incomplete 
 
                                 Peroperative complication:1.csf leak 2.bleeding  3.damage to     
                                                                                   
                                                      internal carotid artery   4.others  5.no complication 
 
POST OPERATIVE COMPLICATIONS:  1.csf leak 2.diabetes insipidus  3.meningitis  
 
                                                                     4.pneumoencephalocoel  5.CVA   6.others                   
                                                                       
                                                                    7.nil   complications                                                                 
                                                       
 
MANAGEMENT OF COMPLICATION: 1.Leak repair  2.desmopressin  3. Antibiotic         
 
                                                                    4.conservative   management of CVA 5.lumbar                  
                                                                        
                                                                      drain  6. Others  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 INFORMATION SHEET 
 
 
We are conducting a retrospective prospective study “A Study Of Pituitary 
Macroadenoma Transnasal Endoscopic Excision” 
 at the Upgraded Institute of Otorhinolaryngology, Madras Medical College & 
Rajiv Gandhi Government General Hospital, Chennai – 600003 
 
 At the time of announcing the results and suggestions, name and identity of the 
patients will be confidential. 
 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
 
 The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
 
 
Signature of Investigator   Signature of Participant 
Date 
 PATIENT CONSENT FORM 
 
Title of the Project  : A Study Of Pituitary Macroadenoma Transnasal Endoscopic 
Excision 
 
Institution    : Upgraded Institute of Otorhinolaryngology, 
     Madras Medical College, 
Chennai – 600003. 
 
Name :     Date   : 
Age  :     IP No. : 
Sex :     Project Patient No. : 
 
 The details of the study have been provided to me in writing and explained to me 
in my own language. 
 
 I confirm that I have understood the above study and had the opportunity to ask 
questions. 
 
 I understood that my participation in the study is voluntary and that  
I am free to withdraw at any time, without giving any reason, without the medical care 
that will normally be provided by the hospital being affected. 
 
 I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s). 
 
I have been given an information sheet giving details of the study. 
 
I fully consent to participate in the above study. 
 ________________  _______________       ___________ 
 Name of the subject         Signature      Date 
 
__________________   _______________       ___________ 
 Name of the Investigator          Signature      Date 
  
ABBREVIATIONS 
MRI- magnetic resonance imaging 
CT-Computed tomography 
GH- growth hormone 
TSH-thyroid stimulating hormone 
ACTH- adenocortico trophic hormone  , 
GnRH-gonadotrophic hormone  
FSH-follicular stimulating hormone 
LH-leutinizing hormone 
ADH-anti diuretic hormone 
DW MRI- diffusion weighted magnetic resonance imaging 
ADC-apparent diffusion coefficient 
NSF-naso septal flap 
CSF-cerebrospinal fluid 
EEEA- extended endoscopic endonasal approach 
DI- diabetes insipidus 
CVA-Cerebrovascular accidents 
 
 
  
 
 
 
 
 
 
MASTER CHART 
 
S.  
No 
Name Age Sex 
Recurrent 
/new case 
Head  
ache 
Prolact 
inoma 
Acro 
megaly 
Visual Defect 
Apo 
Plexy 
Cushing  
Syndrome 
Type of  
Tumour 
Mass  
Effect 
Tumour  
Size (Cms) 
1 indra 43 f new case yes no no no no no non secretory yes 1.7*1.1 
2 krishnan 28 m new case yes no no no no no non secretory yes 3.2*1.9 
3 shanmugapriya 27 f new case yes yes no yes yes no secretory yes 1.2*1.2 
4 margandeyan 49 m new case no no yes no no no secretory yes 1.3*1.5 
5 Lakshmi 27 f new case yes yes no no no no secretory yes 1.3*1.5 
6 Singaravel 49 m new case yes no yes no no no secretory yes 3.6*2.8 
7 Kadharkhan 38 m new case yes no no no no no secretory yes 2.8*3.1 
8 hariff nisha 43 f new case yes no no yes no no non secretory yes 2.5*1.5 
9 selvi 48 f recurrent yes no no no no no non secretory yes 1*3.2 
10 selvendran 32 m new case no no no yes no no non secretory yes 3.1*2.2 
11 Ramu 49 m new case yes no yes no no no secretory yes 2.1*1.2 
12 mohanasundari 24 f new case yes yes yes no no no secretory yes 1.2*1.3 
13 sivagami 58 f recurrent yes no yes no no no secretory yes 2.2*3.1 
14 gunasekaran 55 m recurrent yes no no yes no no non secretory yes 2.3*2.5 
15 kasthuri 43 f new case no no no yes no no non secretory yes 2.1*1.3 
16 parvathi 58 f new case yes no no no no no non secretory yes 1.8*3.1 
17 mufeeda 32 f new case yes no no yes no no non secretory yes 2.1*1.6 
18 ramasamy 55 m new case no no no yes no no non secretory yes 2.8*3.2 
19 rajalakshmi 54 f new case no no no yes no no non secretory yes 3.2*2.6 
20 sadasivam 40 m new case no no no yes no no non secretory yes 2.6*1.8 
21 geethalakshmi 45 f new case no no no yes no no non secretory yes 2.2*2.3 
22 kamala 28 f new case yes no no yes no no non secretory yes 1.6*1.8 
23 anbukarasi 32 f new case yes no no yes no no non secretory yes 2.2*3.2 
24 selvi 45 f new case yes no no no no no non secretory yes 1.8*2.7 
25 marimuthu 38 m new case yes no no no no no non secretory yes 1.7*2.3 
26 mani 25 m new case yes yes no no no no secretory yes 2.5*3.1 
27 jeevan 28 m new case yes yes no no no no secretory no 2.1*3.3 
28 balasubramani 38 m new case no no no no no yes secretory no 1.3*1.8 
 
 
S. 
no 
 Consistency-MRI 
Tumour 
Intensity-MRI 
Tumour 
extention-MRI 
Consistency 
per operative 
Tumour 
Extension- peroperative 
Tumour 
Excision 
1 indra cystic hyperintense sellar cystic similar Complete 
2 krishnan semisolid hyperintense sellar parasellar soft similar Complete 
3 shanmugapriya semisolid hyperintense suprasellar firm not similar incomplete 
4 margandeyan semisolid hyperintense sellar soft similar Complete 
5 Lakshmi semisolid hyperintense suprasellar soft similar Complete 
6 Singaravel semisolid hyperintense suprasellar firm similar Complete 
7 Kadharkhan semisolid hyperintense suprasellar firm not similar Complete 
8 hariff nisha solid hypointense sellar parasellar firm similar Complete 
9 selvi cystic isointense sellar parasellar cystic similar Complete 
10 Selvendran solid hypointense supra sellar parasellar firm similar incomplete 
11 Ramu semisolid hyperintense suprasellar soft similar Complete 
12 mohanasundari cystic hyperintense sellar cystic similar Complete 
13 sivagami solid hypointense suprasellar firm similar incomplete 
14 gunasekaran solid hyperintense supra sellar parasellar firm similar incomplete 
15 kasthuri semisolid hyperintense suprasellar soft similar Complete 
16 parvathi solid hypointense suprasellar firm similar Complete 
17 mufeeda cystic isointense suprasellar cystic similar Complete 
18 ramasamy solid hypointense supra sellar parasellar firm similar Complete 
19 rajalakshmi semisolid hyperintense suprasellar firm similar Complete 
20 sadasivam solid hypointense suprasellar firm similar Complete 
21 geethalakshmi cystic isointense supra sellar parasellar cystic not similar Complete 
22 kamala semisolid hyperintense suprasellar soft similar Complete 
23 anbukarasi solid isointense supra sellar parasellar soft not similar Complete 
24 selvi solid isointense supra sellar parasellar firm similar incomplete 
25 marimuthu solid isointense suprasellar firm similar Complete 
26 mani solid hyperintense supra sellar parasellar firm similar incomplete 
27 jeevan solid isointense sellar parasellar firm similar incomplete 
28 balasubramani solid isointense suprasellar firm similar Complete 
 
 
   Post operative compications   
s.no 
 
Name 
peroperative complication 
 
csf 
leak 
diabetes 
insipidus 
pneumoencephalocoel cva 
Management of 
Complications 
1 indra nil no no no no Na 
2 krishnan nil no no no no Na 
3 shanmugapriya nil no no no no Na 
4 margandeyan nil no yes no no Desmopressin 
5 Lakshmi Csf leak no no no no Leak repair 
6 Singaravel csf leak no no no no Leak repair 
7 Kadharkhan nil no no no no Na 
8 hariff nisha nil no no no no Na 
9 selvi nil no no no no Na 
10 selvendran csf leak no 
yes no 
 
yes 
 
Leak repair, 
cva mgmt and desmopressin 
11 Ramu nil no no no no Na 
12 mohanasundari nil no no no no Na 
13 sivagami Nil yes no yes no lumbar drain and leak repair 
14 gunasekaran csf leak no no no no leak repair 
15 kasthuri csf leak no no no no Leak repair 
16 parvathi Nil no no no no Na 
17 mufeeda Nil no no no no Na 
18 ramasamy nil no yes no no desmopressin 
19 rajalakshmi nil no no no yes cva conservative mgmt 
20 sadasivam nil no no no no Na 
21 geethalakshmi nil no no no no Na 
22 kamala nil no no no no Na 
23 anbukarasi csf leak no no no no leak repair 
24 selvi nil no no no no Na 
25 marimuthu nil no no no no Na 
26 mani nil no no no no Na 
27 jeevan nil no no no No Na 
28 balasubramani nil no no no no Na 
 
